A detailed history of Casdin Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Casdin Capital, LLC holds 8,707,165 shares of BLFS stock, worth $218 Million. This represents 16.93% of its overall portfolio holdings.

Number of Shares
8,707,165
Previous 8,707,165 -0.0%
Holding current value
$218 Million
Previous $187 Million 16.8%
% of portfolio
16.93%
Previous 16.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $8.34 Million - $15.6 Million
927,165 Added 11.92%
8,707,165 $141 Million
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $632,006 - $1.34 Million
58,465 Added 0.76%
7,780,000 $107 Million
Q2 2023

Aug 14, 2023

BUY
$17.19 - $24.34 $2.58 Million - $3.65 Million
150,000 Added 1.98%
7,721,535 $171 Million
Q1 2023

May 15, 2023

BUY
$17.67 - $26.07 $92,643 - $136,685
5,243 Added 0.07%
7,571,535 $165 Million
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $5.3 Million - $7.63 Million
126,185 Added 1.7%
7,566,292 $320 Million
Q4 2020

Feb 16, 2021

BUY
$27.5 - $45.75 $44 Million - $73.2 Million
1,600,000 Added 27.4%
7,440,107 $297 Million
Q3 2020

Nov 16, 2020

BUY
$16.04 - $28.94 $15.9 Million - $28.7 Million
990,583 Added 20.43%
5,840,107 $169 Million
Q2 2020

Aug 14, 2020

BUY
$9.2 - $17.06 $21.9 Million - $40.6 Million
2,380,953 Added 96.45%
4,849,524 $79.3 Million
Q4 2019

Feb 14, 2020

BUY
$14.59 - $18.9 $583,600 - $756,000
40,000 Added 1.65%
2,468,571 $39.9 Million
Q3 2019

Nov 12, 2019

BUY
$15.7 - $20.98 $38.1 Million - $51 Million
2,428,571 New
2,428,571 $40.4 Billion
Q3 2019

Nov 12, 2019

SELL
$15.7 - $20.98 $38.1 Million - $51 Million
-2,428,571 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.99 - $25.48 $21.4 Million - $36.4 Million
1,428,571 Added 142.86%
2,428,571 $42.5 Million
Q2 2018

Aug 14, 2018

BUY
$6.18 - $13.49 $6.18 Million - $13.5 Million
1,000,000 New
1,000,000 $8.33 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.07B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.